The present invention provides a nonaqueous electrolytic solution capable of improving electrochemical characteristics in the case of using an energy storage device at a high temperature and at a high voltage and further capable of inhibiting the gas generation while maintaining a capacity retention rate after storage at a high temperature and at a high voltage and also provides an energy storage device using the same. Disclosed is a nonaqueous electrolytic solution having an electrolyte salt dissolved in a nonaqueous solvent, the nonaqueous electrolytic solution containing a carboxylic acid ester compound represented by the following general formula (I).

##STR00001##

In the formula, each of R.sup.1 and R.sup.2 independently represents a hydrogen atom, a —C(═O)—OR.sup.4 group, or the like, and R.sup.1 and R.sup.2 may be bonded to each other to form a ring structure. R.sup.3 represents a hydrogen atom or the like, and n represents an integer of 1 to 3. When n is 1, then L and R.sup.4 represent an alkyl group having 1 to 6 carbon atoms or the like; and when n is 2 or 3, then L represents an n-valent connecting group, X represents a —C(═O)— group, an —S(═O)— group, an —S(═O).sub.2— group, an —S(═O).sub.2—R.sup.5—S(═O).sub.2— group or a CR.sup.6R.sup.7 group, R.sup.5 represents an alkylene group having 1 to 4 carbon atoms, and each of R.sup.6 and R.sup.7 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms.

The present invention provides a nonaqueous electrolytic solution capable of improving electrochemical characteristics in the case of using an energy storage device at a high temperature and at a high voltage and further capable of inhibiting the gas generation while maintaining a capacity retention rate after storage at a high temperature and at a high voltage and also provides an energy storage device using the same. Disclosed is a nonaqueous electrolytic solution having an electrolyte salt dissolved in a nonaqueous solvent, the nonaqueous electrolytic solution containing a carboxylic acid ester compound represented by the following general formula (I).

##STR00001##

In the formula, each of R.sup.1 and R.sup.2 independently represents a hydrogen atom, a —C(═O)—OR.sup.4 group, or the like, and R.sup.1 and R.sup.2 may be bonded to each other to form a ring structure. R.sup.3 represents a hydrogen atom or the like, and n represents an integer of 1 to 3. When n is 1, then L and R.sup.4 represent an alkyl group having 1 to 6 carbon atoms or the like; and when n is 2 or 3, then L represents an n-valent connecting group, X represents a —C(═O)— group, an —S(═O)— group, an —S(═O).sub.2— group, an —S(═O).sub.2—R.sup.5—S(═O).sub.2— group or a CR.sup.6R.sup.7 group, R.sup.5 represents an alkylene group having 1 to 4 carbon atoms, and each of R.sup.6 and R.sup.7 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms.

A nonaqueous electrolytic solution contains a nonaqueous solvent and an electrolyte dissolved in the solvent. The solution includes a difluoro ionic complex (1-Cis) in a cis conformation represented by the formula (1-Cis), and at least one of cyclic sulfonic acid ester, cyclic sulfonic acid ester having an unsaturated bond, cyclic sulfuric acid ester, cyclic disulfonic acid ester, chain disulfonic acid ester, cyclic disulfonic acid anhydride, nitrile group-containing compound, silyl phosphate ester derivative, and silyl borate ester derivative. ##STR00001##

A nonaqueous electrolytic solution contains a nonaqueous solvent and an electrolyte dissolved in the solvent. The solution includes a difluoro ionic complex (1-Cis) in a cis conformation represented by the formula (1-Cis), and at least one of cyclic sulfonic acid ester, cyclic sulfonic acid ester having an unsaturated bond, cyclic sulfuric acid ester, cyclic disulfonic acid ester, chain disulfonic acid ester, cyclic disulfonic acid anhydride, nitrile group-containing compound, silyl phosphate ester derivative, and silyl borate ester derivative. ##STR00001##

The present disclosure relates to the field of energy storage materials, and particularly, to an electrolyte and an electrochemical device. The electrolyte includes an additive A and an additive B, the additive A is selected from a group consisting of multi-cyano six-membered N-heterocyclic compounds represented by Formula I-1, Formula I-2 and Formula I-3, and combinations thereof, and the additive B is at least one unsaturated bond-containing cyclic carbonate compound. The electrochemical device includes the above electrolyte. The electrolyte of the present disclosure can effectively passivate surface activity of the positive electrode material, inhibit oxidation of the electrolyte, and effectively reduce gas production of the battery, while an anode SEI film can be formed to avoid a contact between the anode and the electrode and thus to effectively reduce side reactions.

##STR00001##

The present disclosure relates to the field of energy storage materials, and particularly, to an electrolyte and an electrochemical device. The electrolyte includes an additive A and an additive B, the additive A is selected from a group consisting of multi-cyano six-membered N-heterocyclic compounds represented by Formula I-1, Formula I-2 and Formula I-3, and combinations thereof, and the additive B is at least one unsaturated bond-containing cyclic carbonate compound. The electrochemical device includes the above electrolyte. The electrolyte of the present disclosure can effectively passivate surface activity of the positive electrode material, inhibit oxidation of the electrolyte, and effectively reduce gas production of the battery, while an anode SEI film can be formed to avoid a contact between the anode and the electrode and thus to effectively reduce side reactions.

##STR00001##

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:

X-A-Y-L-R  (I)

which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:

X-A-Y-L-R  (I)

which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

An electrolyte, electrochemical device, battery, capacitor, and/or the like include a salt; and a fluorinated organosulfate compound represented by Formula I: ##STR00001##
wherein, R.sup.1 is H, OR.sup.3, alkyl, alkenyl, alkynyl, aralkyl, or silyl; R.sup.2 is H, OR.sup.3, alkyl, alkenyl, alkynyl, aralkyl, or silyl; and R.sup.3 is H, alkyl, alkenyl, alkynyl, aryl, heterocyclyl, heteroaryl, or siloxy; or where R.sup.1 and R.sup.2 join together to form a cyclic compound incorporating the —O—S(O).sub.2—O— group; wherein at least one R.sup.1 and R.sup.2 is fluorinated.

An electrolyte, electrochemical device, battery, capacitor, and/or the like include a salt; and a fluorinated organosulfate compound represented by Formula I: ##STR00001##
wherein, R.sup.1 is H, OR.sup.3, alkyl, alkenyl, alkynyl, aralkyl, or silyl; R.sup.2 is H, OR.sup.3, alkyl, alkenyl, alkynyl, aralkyl, or silyl; and R.sup.3 is H, alkyl, alkenyl, alkynyl, aryl, heterocyclyl, heteroaryl, or siloxy; or where R.sup.1 and R.sup.2 join together to form a cyclic compound incorporating the —O—S(O).sub.2—O— group; wherein at least one R.sup.1 and R.sup.2 is fluorinated.